Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LXEO

Lexeo Therapeutics, Inc.

CIK 0001907108 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$4.88
↓ 0.18 (-3.56%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$400.38M
P/E Ratio
-4.59
EPS
-1.86
Dividend Yield
Not covered
52W Position
13%
Beta
1.71

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.70
P/S
Not covered
EV/Revenue
Not covered
ROE
-37.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$3.99$10.99

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$99.96M
Total Assets
$268.69M
Free Cash Flow
-$98.96M

Recent news